Asker Healthcare Issues and Reclassifies Shares to Fund Long-Term Incentive Plan

Asker Healthcare Group AB ( (SE:ASKER) ) has provided an announcement.

Asker Healthcare Group has executed a targeted share transaction to support its employee incentive structure, issuing 670,000 Class C shares, immediately repurchasing them, and reclassifying them into ordinary shares. This maneuver, carried out under a mandate from the August 2025 extraordinary general meeting, increases the total number of ordinary shares to 383,706,497 and provides a pool of 670,000 shares to be used for deliveries under the company’s long-term, performance-based investment share program LTIP 2025.

By structuring the issuance and immediate buyback through Nordea at quota value, Asker ensures a controlled and transparent mechanism for funding its incentive plan without a lasting increase in free-float equity. The newly reclassified shares will be held by the company for allocation to LTIP 2025 participants, underscoring Asker’s emphasis on long-term alignment between employees and shareholders and potentially strengthening talent retention and performance incentives across its European healthcare operations.

The most recent analyst rating on (SE:ASKER) stock is a Buy with a SEK75.00 price target. To see the full list of analyst forecasts on Asker Healthcare Group AB stock, see the SE:ASKER Stock Forecast page.

More about Asker Healthcare Group AB

Asker Healthcare Group is a European healthcare group that partners with caregivers and patients by providing medical products and solutions across 19 countries. The company builds and acquires leading local businesses to support healthcare systems in improving patient outcomes, reducing total cost of care and promoting a fair, sustainable value chain, and it employs more than 4,500 people with revenues of SEK 17 billion.

Average Trading Volume: 562,434

Technical Sentiment Signal: Strong Sell

Current Market Cap: SEK25.09B

See more data about ASKER stock on TipRanks’ Stock Analysis page.